Pacific Biosciences Of California EBITDA Margin 2010-2024 | PACB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Pacific Biosciences Of California ebitda margin from 2010 to 2024. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Pacific Biosciences Of California EBITDA Margin 2010-2024 | PACB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Pacific Biosciences Of California ebitda margin from 2010 to 2024. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$212.6B
Intuitive Surgical (ISRG)	$186.7B
Alcon (ALC)	$45.7B
IQVIA Holdings (IQV)	$39.5B
Edwards Lifesciences (EW)	$38.8B
IDEXX Laboratories (IDXX)	$35.5B
DexCom (DXCM)	$26.9B
Waters (WAT)	$22.9B
SONOVA HOLDING (SONVY)	$22B
STERIS (STE)	$21.3B
Hologic (HOLX)	$18.4B
Fresenius Medical Care AG KGaA (FMS)	$12.5B
Sysmex ADR (SSMXY)	$12.4B
Globus Medical (GMED)	$11.1B
Teleflex (TFX)	$9.2B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.6B
Glaukos (GKOS)	$7.7B
PROCEPT BioRobotics (PRCT)	$5B
Integer Holdings (ITGR)	$4.5B
Inari Medical (NARI)	$3B
TransMedics (TMDX)	$2.9B
Veracyte (VCYT)	$2.9B
LivaNova (LIVN)	$2.8B
Nihon Kohden (NHNKY)	$2.5B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.2B
Integra LifeSciences Holdings (IART)	$2B
RxSight (RXST)	$1.9B
Alphatec Holdings (ATEC)	$1.3B